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Third molar removal is one of the most common oral surgery procedures performed 
in Ireland. Pain, swelling and trismus are well-documented, undesirable 
consequences following third molar removal. These sequelae have a negative impact 
on the patients’ quality of life post-operatively. We aimed to compare the effect of a 
submucosal injection containing 4mg dexamethasone on the post-operative pain 
experienced by the patient versus a control of standard surgical removal of a 
mandibular third molar on the contralateral side. We also analysed patient 
preference of treatment regime. 
 
Methods 
A randomised controlled trial was conducted involving 70 patients undergoing 
surgical removal of bilateral, symetrically-impacted mandibular third molars under 
general anaesthetic in Cork University Hospital. Each patient acted as their own 
control in this split-mouth study, with all treatment carried out at one single visit. All 
subjects received standard local anaesthetic bilaterally in the form of inferior alveolar 
block and long buccal infiltration with 2% lidocaine with 1:80,000 epinephrine. The 
site randomised for intervention received a 1ml submucosal injection of 4mg 
dexamethasone in the buccal vestibule adjacent to the lower third molar following 
administration of local anaesthetic. Both the patient and investigator were blinded 
to the intervention site. The primary outcome measure of pain was self-reported and 
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recorded by the patient for the right and left surgical site for seven days following 
intervention using a visual analogue scale. 
 
Results 
Pain and inflammation are normal physiological responses to tissue trauma such as 
surgery. The age range of the participants in the trial was 16 to 54 years of age, with 
the mean age being 22 years (SD 5.7 years) and median age 21 years. The study 
participants were comprised of 44 females and 26 males. We demonstrated that the 
reported pain scale (VAS 0-100mm) decreases moderately with the treatment 
intervention of 4mg dexamethasone as a submucosal injection (Estimate: -3.32, CI: -
5.36 to -1.28, p < 0.01). 
 
Conclusion 
This trial demonstrated a minor but consistent improvement in analgesic effect when 
submucosal dexamethasone was administered in comparison to control supporting 
the alternative hypothesis. The effect size detected was minimal (estimated 3% 
improvement) and as such deemed not clinically meaningful for patients. Therefore, 
the routine use of submucosal dexamethasone injection in the extraction of 
impacted third molars should not be recommended. 
  
 12 
Declaration of Original Work 
This is to certify that the work I am submitting is my own and has not been submitted 
for another degree, either at University College Cork or elsewhere. All external 
references and sources are clearly acknowledged and identified within the contents. 
Input from other researchers is acknowledged within the text. I have read and 













I would like to take this opportunity to thank the patients who participated in this 
trial, providing their time and effort to complete the study. I would also like to 
acknowledge the guidance and support provided by my supervisor and mentors at 
Cork University Dental School and Hospital, namely Dr. Catherine Gallagher, 
Professor Duncan Sleeman, Dr. Richeal Ni Riordain, Dr. Caroline McCarthy and Dr. 
Paul Brady, four of whom are the skilled surgeons who performed the surgeries 
involved in the trial. Your advice and guidance is greatly appreciated.  
 
Specifically, I would like to acknowledge the work and contribution of Dr. 
Wiley Barton of Teagasc Moorepark, Fermoy, Co. Cork which has been essential to 
completing this project. Your expertise in biostatistics was invaluable to our data 
analysis. 
 
I must also express gratitude to my family for their continued support. It is a 
running joke for my family that I am UCC’s longest serving student, involving constant 
questions as to which course I will sign up for next. Unfortunately, as the realisation 
that my days of representing UCC on a playing field are well and truly behind me a 
life of academia does not sound so bad!  
 
To my husband Owen, thank you for your ever-present support, patience and 
proofreading skills. You made completing a PhD look easy so the undertaking of this 
Clinical Doctorate is partially your fault.  
 14 
Chapter 1: Introduction 
Third molar removal is the most commonly performed oral surgical procedure, 
costing society tens of millions in the United Kingdom and the United States of 
America each year (1-4). There are many factors to consider before a decision to 
remove a mandibular third molar can be reached, involving a through medical, dental 
and social history combined with clinical and radiographic assessment. Removal of 
symptomatic or diseased third molars has been shown to improve oral health and 
function of patients (5, 6). Each patient requires a holistic, tailored approach. Due to 
anatomical variations of the third molar tooth in relation to associated vital 
structures, such as the inferior alveolar nerve, the patient should be involved in the 
treatment decision-making process. The World Health Organisation (WHO) 
characterises the presence of an impacted third molar as a developmental condition 
within their International Classification of Disease (7). However, impaction is a 
descriptive term and is not an indication for surgery when being considered alone. 
Management strategies for mandibular third molars can range from clinical 
monitoring, partial removal in the form of coronectomy or removal.  
 
Following third molar removal, as with other surgical procedures, post-
operative pain is a common undesirable outcome (8-10). It is estimated that 40% of 
patients undergoing day-case surgical procedures experience moderate to severe 
post-operative pain (11). Despite the focus of research investigations on post-
operative pain, it remains poorly managed and a challenge for clinicians (12, 13). 
Post-operative pain negatively impacts on the patient’s quality of life in the days 
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following intervention (14). This negative impact on an individual’s quality of life can 
have a wider socio-economic impact through days absent from the work place to 
allow recovery (15).  
 
There are continual efforts in the literature to explore intra-operative and 
post-operative methods of reducing pain following the removal of mandibular third 
molars (16-18). Intra-operative techniques aimed at minimising post-operative pain 
included comparing various local-anaesthetic regimens (19, 20).  With the 
consistently high numbers of people requiring third molar removal each year, it is our 
aim to undertake a robust clinical trial that can provide reliable evidence to guide 
clinicians in the challenge of minimising the post-surgical pain experienced by the 
patients. In order to achieve a sound study design, our methodology introduced 
some subtle but significant changes when compared to existing trials reported in the 
literature. In clinical trials that investigated the effect of peri-operative 
dexamethasone, various routes of administration were employed ranging from oral 
tablet formulation, intra-muscular, intra-alveolar to intra-venous administration (21-
23). Our clinical trial investigates the effects of the submucosal administration of 4mg 
dexamethasone on pain reported at the surgical site. A submucosal route has the 
benefit of providing local effects but avoiding systemic administration. Furthermore, 
submucosal administration local to the surgical is an accessible site for dentists or 
oral surgeons to access with minimal further training or equipment required.  
 
The majority of clinical trials in this field use a visual analogue scale to 
measure patient reported pain. As pain reported is a subjective measurement we 
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strived to minimise any confounding factors. We set out to achieve this by 
incorporating questionnaires such as the Pain Catastrophising Scale (PCS) to give 
further insight into each patient’s relationship with pain. A key aspect to our study 
design that differs to those previously reported in the literature is the split-mouth 
technique. This study design itself is not novel, however previous clinical trials that 
engaged this design when investigating pain following third molar surgery did so over 
two appointments with a period of weeks between procedures (24). The intervention 
being carried out at two separate visits could lead to the introduction of cross-over 
or observational bias. In our clinical trial patients experience both the intervention 
and control while under general anaesthetic allowing for real-time comparison of the 
surgical sites. The split-mouth design also eliminated the potential for cross-over 
bias. Our inclusion criteria allowed for symmetrically impacted third molars further 
minimising any differences in intervention technique or difficulty at the control or 
intervention site. 
 
     This clinical trial and its primary results have been presented in an oral 
format at the Irish Division Virtual Scientific Meeting 2021 of the International 
Association of Dental Research (25).  
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Chapter 2: Literature review 
2.1 Overview and search strategy 
 
The existing literature was reviewed focusing on three main elements; firstly, the 
development and eruption of the third molars, secondly, the removal of the third 
molars and the associated post-operative experience for the patient and finally how 
we can measure the impact of third molar removal on the patient. 
 
An electronic search was conducted of the Cochrane Library, PubMed and 
MedLine EBSCO databases between the dates of January 1st 2000 and December 31st 
2019. The PICOS framework was followed whilst undertaking the search (Table 1). 
The reference lists of included studies were also searched for any further trials of 
relevance. Inclusion and exclusion criteria were applied to the identified articles and 
any duplicates were disregarded. Eligibility criteria included meta-analysis, 
systematic reviews, randomised controlled trials, controlled trials, participants aged 
over 16 years undergoing removal of at least one mandibular third molar. Studies 
involving the administration of submucosal dexamethasone in varying doses, pre or 
post-operatively were included.  
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Table 1.1 Search strategy 
Population 
#1; Third molars OR wisdom teeth, 




#2; Dexamethasone AND (submucosal OR 
submucosal injection) 
16,075 
Comparison #3; Control OR placebo effect 20 
Outcome 
#4; Post-operative pain AND/OR quality of 
life AND/OR oedema AND/OR trismus 
311680 
Study design 
Randomised controlled trail AND 
controlled trial 
 
Search Combination #1 AND #2 AND #3 AND #4 166 
Database search  
Cochrane Library, PubMed, Medline 
EBSCO 
166 
Limitations applied; Inclusion 
and exclusion criteria 








Pain, swelling and trismus are undesirable consequences of third molar removal. A 
multitude of different interventions aimed at reducing post-operative pain following 
surgical removal of lower wisdom teeth have been researched and reported. Such 
researched interventions range from pre-operative administration of local 
anaesthetic (19), intra-operative interventions including novel surgical techniques or 
alternative local anaesthetic regimes (20, 26) and post-operative interventions such 
as the use of cryotherapy (27). The administration of corticosteroids as a modulator 
of inflammation has been examined in various studies (24, 28, 29), however there is 
no consensus on the optimal route of administration. 
 
There is low-quality evidence that dexamethasone administered as a 
submucosal injection peri-operatively has been found to reduce early stage post-
operative pain for patients (30, 31). High quality evidence is required to provide both 
statistical and clinical significance to results allowing any potential change in practice. 
A review of the literature was undertaken to better understand the post-operative 
experience of the patient undergoing surgical removal of third molars along with the 
methods used to quantify the impact surgery had on the patient. Surgical removal of 
third molars is the most commonly undertaken oral surgical procedure, with lower 
third molars the most commonly impacted tooth (32). In order to better understand 
the potential reasons behind impaction it is important to explore the development 
and eruption pathway of these teeth. Accordingly, this literature review will be 
presented in three sections – third molar development and eruption, extraction and 
 20 




2.3 Third Molars 
 
2.3.1 Development and eruption 
Tooth development and timing of eruption can vary significantly with race and 
ethnicity (33). Third molars erupt between the age of 17 and 24 years, with initial 
development commencing as early as 5 years in certain populations (34). The stages 
of third molar development have been described by Demirijian et al. (35). The 
developmental process of teeth can be a valuable biomarker for age. Demirijian 
described development in eight identifiable stages, ranging from the beginning of 
calcification in the crypt to the final stage of development, closure of root apices (35, 
36).The concept of physiological age is founded on the degree of maturation or 
development of a specific tissue system. Demirijian’s technique is widely used at 
estimating age in populations based on the dental tissue. Timing of development of 
third molars is population specific, occurring at a different age in varying ethnic 
groups (33, 37-39). Crown formation can complete between the age range of 13 - 
15.5 years depending on race (34, 40-42). The timing of eruption can be influenced 
by local factors such as early loss of deciduous tooth however such factors do not 
influence tooth development and formation (43). As with varying degree of tooth 
development at certain age points, the timing of eruption can also vary significantly 
with race and ethnicity (33). 
 
2.3.2 Problems with eruption 
Eruption is a descriptive term to describe the relationship of the crown of the tooth 
in the oral cavity. Teeth can be unerupted, partially erupted, fully erupted or absent. 
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The congenital absence of one or more teeth is known as tooth agenesis. Many 
causes for agenesis are suggested in the literature, some contradictory. An 
individual’s race or genetics, developmental or growth delays along with the 
morphology or size of the jaw are all potential reasons cited as the cause of third 
molar agenesis (44-46). The prevalence of agenesis of one or more third molar varies 
between populations. A systematic review and meta-analysis carried out in 2015 
found a global rate of 22.63% relating to third molar agenesis (47). This systematic 
review found a higher prevalence of one third molar absence over multiples of absent 
teeth. Most commonly the maxillary third molars were found to be absent and with 
a higher prevalence in females (47). 
 
Teeth are said to be impacted if they are prevented from erupting, either 
partially or fully into the mouth. This impaction can be caused by soft or hard tissue, 
including bone or an adjacent tooth. Third molars are the most commonly impacted 
tooth in the arch (48). These impactions can be a result of a lack of space in the arch 
or development of the tooth in an abnormal position (49). 
 
2.3.3 Classification of impaction 
Assessment of the position of the third molar in relation to the surrounding 
anatomical structures is an important step in planning surgical removal and an 
attempt to predict surgical difficulty. Thorough clinical examination and assessment 
of third molars prior to removal is essential. Sufficient assessment of the crown and 
root of the tooth are crucial to minimise unforeseen difficulties encountered during 
the surgery. Mandibular third molars are the most commonly impacted tooth in the 
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human dentition (48). In 2015 a study was published showing 73% of third molars 
are impacted in a European cohort (50). Dachi and Howell looked at the prevalence 
of impacted molars in a cohort of 3874 participants and found the incidence of 
impaction of mandibular third molars to be 17.5% (51). There are various theories 
related to the cause of third molar impaction including the orthodontic theory, 
Polygenic inheritance theory, Mendelian theory, pathological and endocrinal theory 
(52). A classification system for the position of third molars was first proposed by 
Winter in 1926 (53). Four criteria were assessed: position of the crown, character of 
root formation, nature of the bone surrounding the tooth and position of the third 
molar in relation to the second (53). A second classification system of third molar 
impaction was presented by Pell and Gregory in 1933 focusing on the distance from 
the crown of the third molar to the ramus, the relative depth of the third molar within 
the ramus or relative to the occlusal plane along with the position of the third molar 
relative to the long axis of the adjacent second molar (54). These systems aim to 
grade impactions according to the relative difficulty involved in surgical removal (54). 
Unfortunately, studies have shown these assessment tools to be insensitive in 
predicting surgical difficulty, however they are widely accepted as a descriptive 
classification term  (55, 56).  
 
Looking to combine and apply the existing impaction classification systems 
further, Pederson created an index to assess and pre-empt the difficulty for the 
removal of a third molar focusing on three different factors; angulation of impaction, 
depth of the tooth relative to the occlusal surface and the relationship of the tooth 
to the ramus (57). These factors were scored with the sum total corresponding to a 
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difficulty index ranging from slightly difficult to moderately or very difficult. Each 
category had weighted options. A score of greater than five was classified as 
moderately difficult (57). This index has not been validated or widely accepted. 
Independent patient factors such as age, race, sex and bone density are thought to 
play more of a role in difficulty of extraction (58). Studies have shown the most 
relevant of these patient variables to be age, body mass index, root curvature and 
depth from point of elevation (59). Other studies which show that patient age affects 
surgical difficulty, have reported that these older patients undergoing ‘difficult’ third 
molar removal do not report an increase in the pain experienced by the patient in 
the post-operative period (9, 60). 
 
 
Figure 2.1 Classification of third molar impaction as described by Winter and Pell and Gregory 
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2.3 Extraction and Post-Operative Experience 
 
2.3.1 Indications for extraction 
 There is continual debate over management and justification for removal of third 
molar teeth. Guidelines for the management of third molars were first produced in 
1997 by Royal College of Surgeons in England and continue to be revised regularly by 
various expert groups. The National Institute for Health and Care Excellence (NICE) 
published guidance in 2000 advocating against the prophylactic removal of 
mandibular third molars. The NICE guidance was supported by the Scottish 
Intercollegiate Guideline Network (SIGN) in the United Kingdom. Current advice from 
these bodies states the removal of pathology free third molars has no health benefit 
to patients and should be discontinued (49, 61-63). This is contrary to previous 
published studies advocating for the prophylactic removal of third molars (64, 65), 
however the methodology of these studies was open to bias. There is now a growing 
body of evidence suggesting retaining pathology free third molars is simply delaying 
inevitable surgery and the cause of future pathology associated to the site (66, 67). 
NICE are currently updating their guidance following a review of the evidence in 
2015. These changing recommendations have had an effect on the patient 
demographic undergoing intervention for third molars along with improved 
recordkeeping by the dentist reporting the reason for removal. Patient records are 
showing that there has been a reduction in prophylactic removal of third molars and 
an increase in pathology such as caries or recurrent pericoronitis being reported as 
justification for removal of third molars. This change in guidance has also resulted in 
a change of the age profile of patients undergoing third molar removal in the UK. 
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There has been a shift from patients undergoing third molar surgery in their early 
twenties in 1989, where justification for removal was mainly reported as 
prophylactic, to the mid-30 age group of patients undergoing removal in 2008, 
consisting of older adults who have developed pathologies associated with third 
molars, now requiring removal (1). Compliance with the current guidance in the 
United Kingdom was stated to be high due to the low cost of implementation (68). 
Even with the change in guidance, removal of third molars continues to account for 
a significant proportion of oral surgery procedures. The Royal College of Surgeons 
England, Faculty of Dental Surgery published an updated guidance and consensus 
document in April 2021, citing the need for review of the existing guidance due to 
growing evidence suggesting retention of lower third molars is leading to patient 
harm (69). They advocate a number of management options for mandibular third 
molars based on clinical evidence, namely clinical review or intervention when 
indicated. 
 
In the United States of America the latest guidance is evidence-based, 
however the guidance is supportive of the surgeons’ role in providing patient-centred 
treatment and assisting the patient in making a decision that is in their best interest 
(70). This patient-centred approach gives weight to the patients’ thoughts and 




2.3.2 Removal technique 
Surgical removal of an impacted third molar is the most commonly performed oral 
surgery procedure. A variety of techniques can be utilised for the removal of the 
impacted tooth including chisel and mallet, rotary instruments or ultrasonic 
instruments. The earliest documented technique is the lingual split. This technique 
described by Ward involves removing overlying distal bone with a chisel and mallet, 
then fracturing the lingual plate allowing sufficient space to elevate out the impacted 
tooth (71). When compared to more recent techniques such as rotary bur or 
piezoelectric surgery, the lingual split technique causes less pain and swelling for the 
patient, however a higher incidence of nerve injury is observed (72). 
 
Piezosurgey was introduced to oral surgery in 1988 and since then the technology 
has continued to adapt and grow in its uses. The instrument produces micro 
vibrations at a frequency high enough to allow a precise cut (73). An advantage of 
the piezo is its selective cutting, thereby protecting soft tissue, vessels and nerves. 
The disadvantage continues to be the increase in operative time along with the need 
to revert back to the rotary bur if tooth sectioning is required (73, 74). Today the 
most commonly-used technique is buccal bone removal by means of rotary bur and 
external irrigation. This technique can have a shorter operating time when compared 
to piezosurgery (73). However, disadvantages include increased post-operative 
trismus and pain experienced by the patient. No difference is noted in post-operative 
complications in high versus low speed rotary hand piece for buccal bone removal in 
the removal of impacted third molars (75). 
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Procedure duration has been shown to directly impact on post-operative pain 
experienced (76). Some studies show that despite the longer surgical time taken for 
piezosurgery this does not show a significant increase in post-operative pain; 
however this is low-quality evidence open to significant bias (77). Healing post-
operatively was shown to be most delayed following rotary bur technique, followed 
by ultrasonic, then chisel and mallet (78). This slow healing is attributed to the heat 
that may be generated from the instrument causing necrosis of the bone (78). Studies 
have reported the greater the experience levels of the operator in any technique, the 
greater the reduction in post-operative pain reported by the patient (79, 80). 
 
2.3.3 Normal post-operative experience 
Many studies and articles document the morbidity associated with removal of 
impacted third molars and have assessed the impact on quality of life for the patient 
in the days and weeks following surgery. From a patient perspective, pain can be the 
main concern following the removal of third molars.  Data looking at post-operative 
pain can be subjective, as pain experienced by an individual cannot be objectively 
quantified. Conrad et al. surveyed a cohort of 249 patients for 14 days following the 
removal of third molars to investigate the patients’ perception of healing following 
the surgery (60). The cohort was predominantly female and below 25 years of age 
meaning the data would need to be interpreted with some caution as it is not a true 
representative population of all patients undergoing third molar removal. The study 
found that only 30% of patients experienced severe pain on day 1 post-removal. The 
group reported by post-operative day 4 the pain reported was not affecting the 
patients activity levels, however functions such as chewing and mouth-opening were 
 29 
affected ‘quite a bit’ (60). Other studies found the effect on functional ability such as 
eating, speaking and swallowing were the greatest factors influencing a delayed 
return to work for the participant as opposed to pain (81, 82). The subjective nature 
of pain can be seen when studies find women are less likely than men to return to 
work sooner (81). Lopes carried out a prospective study of 522 patients undergoing 
third molar removal over a 12-month period finding 49.2% still complaining of pain 
7-10 days’ post-surgery. Other complaints experienced by lower numbers at this time 
scale included swelling, trismus and paraesthesia. Interestingly they found 81% of 
patients took time off work following surgery, with an average of three days’ sick 
leave. Conversely 19% of patients they looked at took no time off work (83). The 
removal of third molars is consistently the most commonly performed oral surgical 
procedure and with over 150,000 people in England undergoing removal each year, 
the post-operative effects on the patient can have a knock-on effect in society (84). 
Studies carried out in Scandinavia and America investigated the duration of disability 
or loss of productivity for the patients (15, 85, 86). Bienstock and his team 
prospectively observed a cohort of more than 4000 participants, who had 8748 third 
molars removed (15, 85). They included both erupted and non-erupted third molars, 
along with maxillary and mandibular third molars so the figures calculated for days 
absent from work and loss of ability could be conservative at best. Of the third molars 
included in the study, 92% had some pathology associated with the tooth. Regardless 
of these limitations, this group found workers were absent from work for a mean of 
1.3 +/- 1.3 days from work following third molar removal. The range of days absent 
was 0-11 days for the 4004 study participants. The range of days’ patients 
experienced disability to undertake normal activities was 0-26 days. A Swedish study 
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investigating the economic impact of mandibular third molar removal found patients 
had a mean of 1.57 days’ absence from work, with a range of 0-22 days. In this study 
nature of impaction or state of eruption of the third molar were not recorded(86).  
This group calculated the total costs of removing a third molar, inclusive of direct and 
indirect costs such as absence from work, at between €500-1000, which is a 
significant impact on society given the number of patients undergoing removal on an 
annual basis. 
 
 Studies on gender and perception of pain do show women experience pain 
at a higher intensity than men (87, 88). This finding, that women experience a greater 
intensity of pain, is reflected again in a randomised controlled trial involving 92 
patients finding women perceived a bigger impact on quality of life in the days and 
weeks following surgery (89). 
 
2.3.4 Pain following dental surgery 
The surgical site, when removing lower third molars, is a highly vascularised area 
comprised of loose connective tissues. As a result of surgical intervention a series of 
alterations are expected, causing significant morbidity for the patient such as 
swelling, trismus and pain (79, 90). Pain is defined by The International Association 
for the Study of Pain as ‘an unpleasant sensory and emotional experience associated 
with actual or potential tissue damage’ (91). Pain can be a major post-operative 
outcome of any surgical procedure including extraction of wisdom teeth. Pain 
mediators are released from tissues following trauma as an inflammatory process is 
activated. Mediators such as prostaglandin and bradykinin cause firing of peripheral 
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nociceptors. Repetitive firing of these receptors can lead to central sensitisation and 
increased responsiveness of neurons responsible for prolonged pain after surgery 
(92, 93). Patients become increasingly more sensitive to pain the longer they are 
exposed to the stimulus and the firing nociceptor (94). Consistently, surveys have 
shown that post-operative pain is not adequately treated (95, 96). Inhibiting or 
blocking some of these pain and inflammatory mediators are the basis for analgesics. 
Nonsteroidal anti-inflammatory drugs block the synthesis of prostaglandin and 
bradykinin producing their analgesic effect (97, 98). This is done by inactivating 
cyclooxygenase. For oral surgery procedures, onset of pain is generally 4-6 hours 
following the procedure when the local anaesthetic has worn off (99). The teaching 
promoting pre-emptive analgesia is commonplace in dental surgery. This theory has 
been around since the early 1900’s with Crile introducing pre-emptive and 
prevention analgesia in 1913. This involves administering analgesic before the injury 
or surgical procedure to allow it to be operational in minimising the physiological 
consequences invoked by the surgery. Pre-emptive analgesics potentially inhibit 
central sensitisation of central nociceptors and peripheral sensitisation by impeding 
the formation and release of pain mediators in injured tissues at the surgical site (93). 
Further evidence to support pre-emptive nonsteroidal anti-inflammatories was 
provided by Swift and Hargreaves, whose study found significantly reduced post-
operative pain reported by patients having received pre-op analgesics (100). 
Many analgesics tested for pain management are tested using a dental model as 
surgical removal of third molars is a common procedure. This results in a wealth of 
information available on the efficacy of analgesics for dental pain. Combination 
therapy is recommended for acute post-operative pain following third molar surgery. 
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The benefit of a multi-modal approach can be appreciated by understanding the 
pathogenesis of pain and accepting the different pain and inflammatory mediators 
that are being blocked. Paracetamol and non-steroidal anti-inflammatory (NSAIDS) 
drugs can provide moderate pain relief, with opioids (101) providing breakthrough 
pain relief for severe pain. Paracetamol is an anti-pyretic drug with minimal side-
effects (102). Paracetamol is commonly used as part of a multi-modal treatment of 
pain. Paracetamol does not have anti-inflammatory effects so is rarely used alone 
following surgery but in combination with another drug (103). There are some 
studies which suggest that this multi-modal approach is unnecessary with similar 
pain reported using ibuprofen alone versus paracetamol alone in a three day post-
operative follow up; however these studies go against the larger body of work 
reporting otherwise (104). 
 
2.3.5 Influence of corticosteroids on post-operative pain  
As previously mentioned due to the vascular nature of the tissues surrounding lower 
third molars, patients can experience significant swelling and pain post-operatively. 
Localized inflammation at a surgical site due to tissue damage is a normal 
physiological response. Corticosteroids have been used for many years to reduce 
post-operative inflammation; however, their mechanism of action is not completely 
clear. Dexamethasone is a corticosteroid with mainly glucocorticoid effects, first 
synthesised in 1957 (105). There is greater affinity for dexamethasone than 
endogenous cortisol at the glucocorticoid receptors (106). Dexamethasone binds to 
the receptor, releasing an activated complex. This steroid-protein complex initiates 
changes in DNA of target genes. These target genes in turn lead to the synthesis of 
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new proteins, which initiate a further biological response. The main result of this 
reaction is the blocking of multiple inflammatory genes, supressing prostaglandin 
and bradykinin formation (107, 108). Bradykinin is an inflammatory mediator 
produced at the site of tissue trauma causing pain (109). Furthermore, 
dexamethasone prevents the build-up of leukocytes and macrophages at the surgical 
site, this is a result of the glucocorticoid causing apoptosis in inflammatory cells 
reducing the cellular immune response (108). Inflammation is a normal physiological 
response to tissue trauma and a certain inflammatory response is required for 
healing. The cardinal signs of inflammation include calor (heat), dolor (pain), rubor 
(redness) and tumor  (swelling) (110). Excessive levels of swelling and inflammation 
lead to pain and reduced quality of life for the patient (111). It is our hope that in 
reducing the levels of inflammation experienced by the patient following a 
submucosal injection of dexamethasone, we will minimise the pain experienced local 
to the surgical site. 
 
2.3.6 Dexamethasone and third molar removal 
Studies have looked at the effect of dexamethasone as a pharmacological method of 
reducing the pain, swelling and trismus following third molar removal (24, 28, 29).  
Corticosteroids administered in a variety of routes have been shown to reduce post-
operative swelling, however these studies lack comparability or homogeneity (112). 
Several different protocols of dexamethasone, including differing route of 
administration and dosage have been described but no consensus or guidance has 
been standardised. There are confounding factors affecting accurate comparison 
between studies, such as the formulation of medication, variety of routes used to 
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administer steroids, the dosage of steroid, the presence of infection at the time of 
extraction (24, 112). The optimum steroid used should reduce local inflammatory 
reactions but have little effect systemically. Dexamethasone has good glucocorticoid 
effect and causes minimal sodium retention, properties which support its use in 
dentoalveolar surgery. As such, dexamethasone fits the criteria for having negligible 
mineralocorticoid activity yet a great biologic effect. Dexamethasone also has a long 
half-life of 36-54 hours which is much greater when compared to other 
corticosteroids such as hydrocortisone (111). Submucosal administration has 
advantages when compared to other routes of delivery including low dosage of drug 
required for effect, drug administration close to the surgical site and low systemic 
absorption of the drug resulting in fewer side effects (111). The short term exposure 
and low systemic absorption of the drug results in minimal systemic uptake and 
adverse effects (24).  
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2.4 Measuring the Impact of Third Molar Extraction on Patients 
 
2.4.1 Patient reported outcome measures 
Patient reported outcome measures (PROMs) are often used in clinical practice to 
gain feedback on patients’ perceptions and views of their health and their healthcare 
experience. These self-reported questionnaires can help quantify and give weighting 
to the subjective feelings and views of the patient regarding various outcomes such 
as pain or quality of life (113, 114). PROMS have been shown to facilitate increased 
communication between patient and clinician which in turn can lead to shared 
decision-making for treatment (115, 116). Surveys of clinicians have shown a majority 
of professionals who use PROMs utilise them as a means to track patient progress 
(117). There are many tools for assessing patient based outcome measures in clinical 
trials varying from site-specific, to disease-specific to generic. Fitzpatrick et al. set out 
criteria of eight items to be used by researchers when evaluating and selecting the 
patient-based outcome measures to be used in their clinical trial (118). These criteria 
were compiled following a comprehensive review of the literature surrounding 
PROMs; however, it must be recognised that this is a qualitative summary of the 
findings and expert opinion. Therefore, the criteria set out by this team may be 
flawed and should be interpreted with care. The eight criteria include, 
appropriateness, reliability, validity, responsiveness, precision, interpretability, 
feasibility and acceptability. The use of patient-centred outcome scales is now seen 
as invaluable. This is compounded by the finding that surgeon-reported success 




The visual analogue scale (VAS) is a one-dimensional scale to measure the pain 
intensity experienced at a given time. It does not give descriptors of the type of pain 
being experienced by the patient. A visual analogue scale is a line anchored with 
terms such as ‘no pain’ and ‘worst pain possible’, where the patient is requested to 
mark on the line indicating where their pain equates. The VAS can be depicted as a 
vertical or horizontal line, with greater reliability observed with the horizontal style 
(119). VAS is validated as a measure of pain for patients suffering from chronic pain 
(120, 121). There has been some criticism of VAS following procedures under general 
anaesthetic. 
 
 Other tools used to report pain experienced include a Numeric Rating Scale 
(NRS) or a Verbal Descriptor scale (122). The NRS was developed in 1984 and gives a 
unidimensional report of the pain. Pain is reported using a numeric value 0-10, 
descriptors of boundaries are often ‘no pain’ to ‘worst possible pain’. The NRS has 
been shown to be useful in patients in both young and old age groups, those patients 
with poor English or for use in phone surveys where the investigator can record the 
number reported by the patient (123). 
 
Questionnaires such as the short form McGill Pain Questionnaire can provide 
more information related to the pain, providing sensory descriptors relating to the 
pain in combination with a pain intensity score (124). This questionnaire gives a 
second dimension to the pain measures by engaging three tools to provide 
information about the type of pain experienced rather than simply the present pain 
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intensity. This questionnaire utilises descriptive words, a VAS and a Verbal Descriptor 
Scale (VDS) to gather as much information as possible about the pain being 
experienced by the patient. This questionnaire has repeatedly been shown to be valid 
(124, 125). There are eleven descriptive terms and three affective terms each scored 
by the patient. The SF McGill quantifies the overall present pain intensity experienced 
by the patient, using both a 100mm visual analogue scale and a six point Likert scale 
with end points ‘None’ to ‘Excruciating’. Verbal Descriptor Scales (VDS) were first 
introduced in 1968 by Keel. Used alone they have limited value as the words used 
are restrictive; however, they have been adapted and included in questionnaires 
such as the SFMcGill pain questionnaire (123). When used in combination with other 
scales they can give further insight into the pain experienced. 
 
2.4.3 Oral health related quality of life 
Quality of life is a multidimensional concept. It can be defined as a measurement of 
the impact a disease or treatment has on a patient’s daily life, wellbeing and 
functioning. The main tools used for the assessment of quality of life are self-
reported questionnaires. Oral health-related quality of life questionnaires aim to look 
at the impact an oral condition has on the patients daily activities and social 
interaction (126). Patient-reported outcomes are an increasingly important measure 
in success of treatment in a patient-centred approach to treatment. Although quality 
of life is a subjective it should be a key focus of patient-centred treatment. The Oral 
Health Impact Profile (OHIP) was developed in 1994 by Slade (127). This 49-point 
questionnaire aimed to provide a self-reported measure of oral discomfort, 
dysfunction and disability. The questionnaire was modelled on the concepts 
 38 
described the World Health Organisation’s classification and hierarchy of impacts of 
a disease and Lockers model of oral health (128, 129). A shortened validated 14-item 
version (OHIP-14) was developed by Slade in 1997 which was found to be short, 
practical and easy to complete (130). The fourteen statements relate to the 
functional, physical, psychological and social impact a specific oral disorder is having 
on the patient’s quality of life. In this study, the impact of interest is that associated 
with impacted mandibular third molar teeth (Appendix VI). Each statement is scored 
on a four-point Likert scale including ‘never’, ‘sometimes’, ‘often’, ‘always’. The 
greater the sum total of the score, the greater the impact of the impacted mandibular 
molars on the patient’s well-being. A maximum score of 42 is possible. It should be 
noted that all measures in the OHIP questionnaire are adverse or negative outcomes 
so no possible positive outcome can be derived (131). Questionnaires focusing on 
quality of life can provide a subjective perception of the impact a disease or 
treatment intervention can have on a patients overall wellbeing in the short or long 
term. 
 
2.4.4 Patient anxiety and personality and pain 
Correlation has been seen between pain reported and the personality of the patient. 
This can be rationalised as the nature and severity of pain is a product of the tissue 
damage along with patient cognitive experiences. Studies have shown that anxiety 
and stress can be tied to the reported pain level (132). Many studies have shown a 
link between high anxiety levels pre-operatively and greater perceived pain levels 
following an intervention (133, 134).  It is thought that this heightened pain can be 
reasoned as an attentional bias towards the pain (135). To identify any probable 
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predisposing and undiagnosed anxiety or depressive disorders investigators can 
utilize tools to identify probable cases of anxiety and depression within the study 
population. The Hospital Anxiety and Depression Scale (HADS) was developed in 1983 
by Zigmond and Snaith (136). HADS is a fourteen-item, self-rated scale designed to 
assess psychological distress in a non-psychiatric population (Appendix IV) (136). This 
questionnaire is a concise yet effective measure used to identify anxiety levels. This 
scale is easy to complete in a pre-admissions area and takes approximately 5 
minutes.  This is critical in our study where there are varying levels of anxiety among 
patients regarding extraction and in order to reduce confounding factors. It was 
originally designed to identify depression and anxiety disorders away from a 
psychiatric hospital setting and has been found to be effective (137, 138). The 
questionnaire is broken down into two subscales, 7 items forming an anxiety subscale 
and 7 items in a depression subscale, with the items intermingled throughout. Each 
item is scored by ticking one of four responses which relates best to the patient, 
ranging from “no not at all” to “yes definitely”. These responses are scored from 0-
3. The maximum score in each subscale is 21. A score ranging between 8-10 is 
considered a mild or possible case of anxiety and/or depression and a score ≥11 as a 
probable case of psychological distress (136).  A score of 0-7 inclusive represents a 
non-case. HADS has been widely validated across a number of clinical specialities, 
including dentistry (139-141). HADS has been shown to be a reliable tool for assessing 
and screening for anxiety and depression in a non-psychiatric setting (137).  
 
The Pain Catastrophising Scale  (PCS) was developed in 1995 by Sullivan et al. (142). 
Catastrophising was defined in 2001 by Sullivan as ‘ an exaggerated negative mental 
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set brought to bear during actual or anticipated painful experiences’ (143). 
Catastrophising is seen as multidimensional, comprising of rumination, magnification 
and a feeling of helplessness. Catastrophisers were described as people who had a 
tendency to magnify or exaggerate the value of a pain (144). Sullivan designed and 
developed his scale using concepts from previous studies on catastrophising (144-
146). The questionnaire consists of 13 statements describing the thoughts and 
feelings one may experience while in pain. The statements are broken down into 
three subscales; Rumination, Magnification and Helplessness. Each statement allows 
the patient to reflect on a time when they have experienced pain and how they 
reacted to the pain at that time. Each item is scored on a five-point scale with end 
points (0) not at all and (4) all the time. The PCS has a maximum possible score of 52. 
The likelihood of catastrophising increases with an increasing score. Those scoring 
>30 are identified as clinically relevant. This information allows us to interpret the 
reported pain scores with greater sensitivity. This scale has been validated as being 
a significant predictor of physical and emotional distress expressed by an individual 
when experiencing pain (142). Other studies prior to the development of this tool 
have also shown a relationship between patient distress and catastrophising and the 
amount of pain expressed or tolerated (147-149). This scale is important to aid 
clinicians in interpreting self-reported pain measures with greater sensitivity.  
 
Dental phobia is one of the most common fears and phobias reported (150). 
Women are found to be more likely to report a dental fear or phobia than men (151, 
152). Dental fear has previously been described as a conditioned reaction to a 
previous experience or traumatic event; however it is thought that it may have links 
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to patient anxiety disorders (153-155). Patients with high dental anxiety are found to 
report greater pain at recall following procedures such as tooth extraction (156), 
again highlighting the importance of getting baseline anxiety and catastrophising 
scores for studies where self-reported pain is a primary outcome. 
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2.5 Summary of Literature Review 
 
Third molars erupt between the age of 17 and 24 years, with variation seen due to 
race and ethnicity. Mandibular third molars are the most commonly impacted tooth 
in the arch (48). Surgical removal of third molars is the most commonly performed 
oral surgery procedure. Due to changing guidance there has been a shift in age profile 
of the patients undergoing third molar removal in the United Kingdom, from patients 
in their early twenties in 1989, to patients in their mid-thirties in 2008 (1). This shift 
in patient age profile could have a potential economic impact due to a greater 
number of patients being in full-time employment rather than education. Various 
techniques are recognised for surgical removal of third molars.  Buccal bone removal 
with external irrigation is the most common method today. 
 
There is significant short-term morbidity associated with the removal of 
impacted third molars. Both pain and the impact on oral function such as eating or 
speaking has been found to delay a return to work for patients with studies reporting 
absence from work of up to 26 days following removal. Following surgical trauma, 
pain and inflammatory mediators are released at the surgical site. For oral surgery 
procedures, onset of pain is generally 4-6 hours following the procedure when the 
local anaesthetic has worn off. Interventions should be taken to minimise the post-
operative pain experienced by the patient. The benefit of a multimodal approach to 
post-operative can be seen when pain and inflammatory mediators are targeted. 
Surveys have consistently shown that post-operative pain is not adequately treated 
(95, 96). Dexamethasone is a corticosteroid with mainly glucocorticoid action. Once 
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bound to the receptor, dexamethasone initiates a chain of events resulting in the 
suppression of inflammatory mediators. The optimum steroid used should reduce 
local inflammatory reactions but have little systemic effect. Dexamethasone fits this 
criterion as it has negligible mineralocorticoid activity yet a great biologic effect. 
 
Patient-reported outcome and experience measures can help quantify the 
subjective feeling and views of the patient regarding various outcomes such as pain 
and satisfaction. The visual analogue scale (VAS) is a one-dimensional scale to 
measure pain intensity at a given time point. Descriptive questionnaires, such as the 
Short Form McGill Pain Questionnaire can provide a second dimension to the pain 
experienced. Some correlation has been shown linking patient gender, personality 
type, and anxiety levels with the degree of pain reported. 
  
 44 
2.6 Knowledge Gaps and Study Aims 
 
Although there is a body of low-quality evidence to suggest submucosal 
dexamethasone may reduce post-operative pain in the short term there is a lack of 
high quality, randomised controlled trials. Following a review of the literature we 
decided to carry out a prospective, double-blind, split-mouth, randomised controlled 
trial investigating the effect of a submucosal injection of 4mg dexamethasone on 
post-operative pain following third molar surgery. Secondary outcomes of patient 
preference of treatment modality and interference with speech or diet were also 
assessed. 
 
In our study we hypothesise a submucosal injection of dexamethasone will 
reduce the pain experienced by the patient and decrease the impact on quality of life 
for the patient following third molar surgery. Our unique angle is assessing the 
response to submucosal administration of 4mg dexamethasone as a submucosal 
injection versus a control of no injection, in a patient requiring surgical removal of 
bilateral, symmetrically impacted wisdom teeth, at the same visit. To the best of our 
knowledge this methodology has not been previously carried out. As the patient is 
acting as their own control, confounding factors (age, bone density, race, smoking 
status) are limited greatly. The patient is blinded to the intervention site minimising 
any reporting bias. Furthermore, the patient is having both lower third molars 
removed at the same appointment allowing for a real-time comparison of pain 
experienced and, eliminating cross-over bias. Treatment is carried out under general 
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anaesthetic, which has the benefit of ensuring the patient is blinded to the 





H0: There is no difference in post-operative pain following surgical removal of lower 
third molars when a submucosal injection of 4mg dexamethasone is administered in 
the buccal vestibule pre-operatively. 
H1: There is a difference in post-operative pain following surgical removal of lower 
third molars when a submucosal injection of 4mg dexamethasone is administered in 
the buccal vestibule pre-operatively. 
H0: There is no difference in patient preference following treatment when 4mg 
dexamethasone is administered as a submucosal injection pre-operatively compared 
to no dexamethasone injection during the surgical removal of mandibular third 
molars. 
H1: There is a difference in patient preference following treatment when 4mg 
dexamethasone is administered as a submucosal injection pre-operatively compared 




2.8 Aims and objectives 
 
Study aim: To confirm the reduction in post-operative pain experienced by the 
patient and to reduce any impact on quality of life experienced by the patient via the 
administration of a submucosal injection of dexamethasone at the surgical site. 
 
Objectives 
 To determine if a single dose submucosal injection of dexamethasone local to the 
surgical site has an effect on the period of acute post-operative pain in comparison 
to local anaesthetic alone. 
 To assess the patients’ quality of life in the days following surgical removal of lower 
third molars, local anaesthetic alone versus local anaesthetic plus submucosal 
dexamethasone 
 To determine patients’ post-operative preference and satisfaction with regard to a 
submucosal injection of dexamethasone versus local anaesthetic alone during lower 
third molar extraction 
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Chapter 3: Materials and Methods 
3.1 Ethical Approval and informed consent 
 
Prior to commencement, ethical approval was sought and granted by the Clinical 
Research Ethics Committee of the Cork Teaching Hospitals (CREC), reference number; 
ECM4(b)18/06/19 (Appendix I). All volunteers provided written informed consent 
before participation (Appendix II). 
 
3.2 Study Design 
 
We designed a split-mouth, randomised controlled trial in which the volunteer 
received either the intervention or control at both the lower left and lower right 
mandibular quadrant. Treatment was carried out in one session, with the patient 
under general anaesthetic. Patients completed questionnaires both pre- and post-
operatively. Data collection was continued daily for seven days following the 
procedure, with each participant required to complete daily pain questionnaires. 
We used a per-protocol analysis of the final data. 
  
 49 




3.3 Sample Size 
 
A sample size of 52 was calculated to have a power of 80% to detect a mean 
difference of 10mm between the treatment and control groups on the visual 
analogue scale (VAS), representing pain levels. An approximate standard deviation of 
25 was used. This standard deviation was calculated based on the mean difference 




Seventy participants requiring bilateral mandibular third molar removal under 
general anaesthetic were recruited from a treatment waiting list at Cork University 
Dental School and Hospital requiring bilateral mandibular third molar removal under 
general anaesthetic. All patients were assessed by a dentist or oral surgeon in Cork 
University Dental School and Hospital prior to placement on the treatment waiting 
list. Each patient had an orthopantomogram at the consultation prior to placement 
on the treatment waiting list. This radiograph was assessed by a single investigator 
(MC) prior to recruitment in order to ensure the inclusion criterion, of symmetrical 
impaction of the lower third molars, was met. 
 
Inclusion criteria:  
 Male and female >16 years 
 ASA 1 or ASA2 (157) 
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 Radiographically symmetrically impacted mandibular third molars as classified by 
Winter’s criteria requiring surgical removal 
Exclusion criteria: 
 Pregnant or lactating women 
 Use of non-steroidal anti-inflammatories within the 24 hours prior to surgery 
 Pre-existing pain conditions 
 Poorly-controlled systemic diseases or learning disability 
 Patient refusal 
 Allergy to dexamethasone 
 
3. 5 Randomisation 
 
Each study participant would experience both the intervention and control due to 
the split-mouth study design. The site to receive the intervention was randomly 
selected. The Randomisation sequence was carried out independently by a 
statistician. For each surgeon (four surgeons), blocked randomisation was used to 
ensure that equal numbers of patients received the treatment on the lower left and 
right quadrants. Six blocks of size four and 2 blocks of size two in this order (AABB, 
ABAB, ABBA, BABA, BBAA BAAB, AB, BA) were set. Blocks of size 2 were used to aid 
concealment of the randomisation scheme. The 8 blocks were randomised using a 
uniform random number generator in STATA with values between 0 and 1 (158). The 
first 8 random numbers were placed in order beside the 8 blocks and the two 
columns were then sorted from highest to lowest according to the random number. 
The letters defined the assignment of the treatment as follows: 
 52 
A= Dexamethasone Injection Site: Lower Right (Quadrant 4) 
B= Dexamethasone Injection Site Lower Left (Quadrant 3) 
The first 18 Letters were used for the random assignment of treatment site 
for Surgeon A. The randomisation method was then repeated for the three other 
surgeons. Surgeon number, patient study number and the intervention site were 
printed on individual labels and placed on post-cards inside a sealed envelope. The 
outside of the envelope had the surgeon code and patient study number.  An 
example of the post-card contained inside the opaque envelope is shown in Figure 
3.2. 
 
Figure 3.2 Sample Randomisation post-card once removed from the sealed opaque envelope 
 
 
The researcher (MC) was blinded to the treatment site until statistical analysis 
was completed. Each case was numbered sequentially as they were recruited. For 
each case the randomly selected site for intervention was given to the surgeon in an 
identical, sealed, non-transparent envelope as described immediately prior to the 
surgery. The investigator was not involved in the surgery in order to maintain 
impartiality. The patient was under general anaesthetic for the procedure and 
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remained blinded to the site that received the intervention of interest, submucosal 
dexamethasone.  
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3.6 Operative Intervention 
 
All patients received perioperative analgesics. Either oral pre-operative analgesics or 
intra-operative intravenous analgesics were used depending on the date of 
treatment. Due to a change in admission facilities resulting from Cork University 
Hospital’s response to Covid-19, our dental theatre staff were no longer able to safely 
administer oral pre-medications to patients. This was due to a reduced capacity 
admissions and recovery area for the patients and as such made privacy and 
supervision of pre-operative patients challenging for the nursing staff. As there was 
insufficient space to administer medication and supervise the patient we had to 
adjust our pre-medication protocol. As a consequence, study participants recruited 
after April 2020 received intravenous analgesics intra-operatively as opposed to oral 
analgesics pre-operatively. Pre-operative oral analgesia consisted of paracetamol, 
ibuprofen and oxycodone. For those recruited after April 2020, intravenous 
paracetamol and diclofenac were administered intra-operatively. 
 
The patient was monitored non-invasively with electrocardiography, pulse 
oximetry and blood pressure monitoring prior to induction of anaesthesia. Each 
patient received a standardised general anaesthetic provided by a consultant 
anaesthetist. Anaesthesia was induced with intravenous propofol and maintained 
with a sevoflurane in oxygen mixture. Following pre-oxygenation, the patient was 
intubated with a nasoendotracheal tube of appropriate size. Intra-operative 
anaesthetic and vital sign monitoring included heart rate and rhythm, anaesthetic 
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depth, oxygen saturation, end tidal carbon dioxide, blood pressure and sevoflurane 
in oxygen concentration. 
 





A standard surgical trolley was set up prior to all procedures. Using aseptic 
technique, 1ml of 4mg/ml dexamethasone was drawn up from a 2ml ampule into a 
labelled 5ml syringe by the investigator (MC) and placed on the trolley for the 
surgeon. Bilateral mandibular third molar removal was carried out by a single, 
experienced surgeon for each patient. Regional anaesthesia of an inferior alveolar 
nerve block and long buccal infiltration of 2% lidocaine with 1:80,000 epinephrine 
was administered to the lower right and left quadrant, immediately prior to incision. 
A 2.2ml cartridge was used for the inferior dental block followed by a further 2.2ml 
as a long buccal infiltration were delivered. The site randomised for the intervention 
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received a 1ml injection of 4mg dexamethasone, via a 22-gauge needle, in the buccal 
vestibule adjacent to the lower third molar following administration of local 
anaesthetic. 
 
All cases involved raising a full-thickness mucoperiosteal flap. Buccal bone 
removal and sectioning of the tooth was carried out as required using a surgical bur 
and copious irrigation. In suitable cases the tooth was sectioned using a hammer and 
osteotome, negating the requirement for buccal bone removal. The tooth was 
delivered from the socket using a Coupland’s elevator. Each socket was irrigated with 
normal saline and the flap replaced using 4.0 Vicryl absorbable sutures. Duration of 
surgery, from incision to final suture placement, was recorded individually for the 
right and left mandibular third molar removal by the investigator (MC), who was in a 
room adjacent to the theatre.  
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3.7 Pre-operative data collection 
 
Patient demographics including age, gender, smoking status, and contact details 
were recorded following informed consent to study participation. A number of 
baseline questionnaires were completed by the patient under the supervision of the 
investigator (MC). Facilitated by MC, the Pain Catastrophising Scale, Hospital Anxiety 
and Depression Scale and the Oral Health Impact Profile-14 were completed pre-




3.8 Post-operative Data Collection 
 
Immediately post-operatively the surgeon completed a standardised surgical 
questionnaire. Details of the surgery including state of tooth eruption, extraction 
technique employed, classification of impaction, along with assessment of difficulty 
were recorded. These details were recorded individually with respect to right and left 
surgical site. 
 
3.8.1 Surgical Questionnaire 
3.8.1.1 State of Eruption 
The state of eruption and nature of impaction of the mandibular third molars 
involved in this study were assessed at two stages. Initially, in order to meet the 
inclusion criteria of this study, an orthopantomogram of potential study participants 
were assessed by a single investigator (MC) and if deemed to have symmetrically 
impacted lower third molars for removal, patients were offered recruitment in the 
study. This step was taken prior to enrolment to ensure the paired samples, for the 
intervention and control side, were closely matched and the subject met the 
inclusion criteria of the trial. A second assessment of the state of eruption and nature 
of impaction was reported and recorded by the operating surgeon immediately 
following surgery, using our surgical questionnaire (Appendix VII).  Aided by this 
questionnaire the operating surgeon assessed and recorded the state of eruption, 
from unerupted to partially erupted or fully erupted as they identified intra-orally. 
Due to the required surgical element of the trial no fully erupted third molars met 
the inclusion criteria. 
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3.8.1.2 Classification of Impaction 
The nature of the impacted third molars were classified accorded to Winter (53). This 
was recorded for each case by the operating surgeon with respect to the intervention 
and control side. To be eligible for enrolment in the study a single investigator (MC) 
had classified the impaction of the mandibular third molars from a radiograph 
deeming the right and left molar to be symmetrically impacted. 
 
3.8.1.2 Surgical technique 
Depending on the type and cause of the impaction (bone/soft tissue/adjacent tooth), 
differing surgical techniques may be employed to relieve the impaction, allowing for 
the removal of the tooth by elevation. The operating surgeon recorded the surgical 
technique employed in each case on the surgical questionnaire immediately 
following the procedure. As no tooth was fully erupted in the mouth, all cases 
involved surgery of some kind. All surgical techniques involved raising a full-thickness 
mucoperiosteal flap (FMPF). 
 
3.8.1.3 Difficulty of Extraction 
Immediately following surgery, the operating surgeon ranked the difficulty of the 
extraction. Although this is a subjective measure the ranking was requested to give 
further surgical information to any potential outlying pain scores. Three tick box 
options were given to the operating surgeon, routine, complex or highly complex. 
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3.8.2 Pain Assessment 
Thirty minutes following extubation, two further questionnaires were completed by 
the patient assisted by the investigator (MC). These included Short form McGill Pain 
questionnaire and a pain diary. 
 
3.8.3 Short Form McGill Pain Questionnaire 
This questionnaire was used to investigate the multi-dimensional nature of pain, 
investigating the characteristics of the pain being reported by the participants in 
combination with a VAS and a Present Pain Intensity scale (PPI) (Appendix VIII). The 
SF McGill incorporates the overall intensity of the pain using the VAS and PPI scores, 
complimented by descriptive, sensory and affective subscales. 
 
3.8.4 Pain Diary 
Patients were required to complete a structured pain diary for seven days following 
surgery (Appendix IX). The pain diary contained quality of life and functional 
questions, a record of analgesic consumption and a Visual Analogue Scale (VAS) to 
assess pain experienced at the right and left surgical site independently. The VAS 
scale was 100mm in length, 0mm equating to no pain and 100mm equating to 
maximal possible pain. 
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3.9 Discharge Advice 
 
Prior to discharge, the patient and their chaperone received standard post-operative 
instructions. A standard prescription and directions for use were given pertaining to 
post-operative analgesia. Post-operative analgesics consisting of paracetamol 1g six 
hourly and a non-steroidal anti-inflammatory, dexketoprofen 25mg eight hourly 
were prescribed. An opioid, oxycodone 5mg tablets 4-6 hourly as required, was also 
prescribed for breakthrough pain. No patients received a prescription for 
prophylactic antibiotics. Each patient was discharged with a questionnaire pack and 
a stamped addressed envelope for ease of return upon completion. The 
questionnaire pack comprised of a pain diary and Short form McGill Pain 
Questionnaire, each to be completed daily for seven days. On day 7 post-operatively 
two additional questionnaires were required; the Hospital Anxiety and Depression 





Each patient was contacted by telephone on post-operative day 4 and post-operative 
day 7 in order to check-in with the patient and to ensure return of the questionnaire 
pack following completion. 
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3.11 Patient Satisfaction 
Patient-satisfaction is an important measurement in any patient-centred treatment. 
The Dental Visit Satisfaction Scale is a ten item scale, with three subscales of 
communication, understanding and competence developed by Corah et al. in 1985 
(Appendix X) (159). Patient-satisfaction can be used as a measurement of treatment 
success. A patients expectation of a what is a good service can vary greatly, 
depending on patient age, gender, nature of the illness and their attitude towards to 
problem (160). The Dental Visit Satisfaction Scale is best suited to assessing outcomes 
from a single dental visit; it is a short and practical tool that is suitable for rapid 
completion following the visit. Patients are to respond to each of the ten satisfaction 
questions, which are presented in a five-point Likert style ranging from ‘Strongly 
Disagree’ to ‘Strongly Agree’. We required study participants to complete this 
satisfaction scale on day-7 following treatment. As the treatment was carried out 
under general anaesthetic, question 8 (‘The Dentist was too rough when he worked 
on me’) was not directly applicable. Patients were asked to respond to each of the 
ten satisfaction questions.  
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3.12 Statistical Analysis 
 
Statistical analysis was performed with assistance of a biostatistician, Dr. Wiley 
Barton from Teagasc Moorepark, Fermoy, Co. Cork. All statistical analysis was 
conducted within the R statistical software environment (161) using version 4.0.1 and 
RStudio (v.1.3.959) (162) on Windows 10. Data was imported to R and assessed for 
normality using the MVN (v.5.8) package with the Mardia’s multivariate normality 
test (163). Normality testing determined a non-normal distribution of the study’s 
variables. Non-parametric tests were used accordingly. Wilcoxon signed rank and 
rank-sum tests were used to compare paired and unpaired variables, respectively. 
Spearman’s correlation was used for the comparison of association between 
variables. All p-values were adjusted for multiple comparisons using the Benjamini–
Hochberg method with an adjusted p-value < 0.05 used to measure significance 
(164).  
 
Regression analysis was implemented with lm from the base stats package 
and the lmer function from lme4 (v.1.1-23) (165). Linear mixed-effects model 
generation resulted from repeated step-down comparison of variable effects, 
resulting in a model with functional least complexity. A significant contribution of 
variables was determined with an ANOVA p-value < 0.05 and comparison of Akaike 
Information Criterion and Bayesian Information Criterion (AIC and BIC, respectively). 
The final model comparing treatment effect on reported VAS score included surgery 
time, eruption state, and pain diary day as fixed variables and volunteers as the 
random effect with pain diary day weights added. Graphical representations were 
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generated using the ggplot2 (v.3.3.1) package (166). Regression model plots used 
fitted lines for un-weighted simple regression (SurgeryT vs. VAS/ Figure X), locally 
fitted loess regression (days vs. VAS), and mixed-effect linear regression with ribbons 




Chapter 4: Results 
4.1 Demographics 
 
Seventy patients were enrolled in the study between October 2019 and October 
2020. The age range of the participants was 16 to 54 years of age, with the mean age 
being 22 years (SD 5.7 years). The median age of our study population was 21 years. 
The study participants were comprised of 44 females and 26 males. The majority of 
the participants, 82.86%, were non-smokers. Table 4.1 demonstrates the clinical and 
demographic characteristics of the study population as a whole and as treated by 
each surgeon. 
 
Table 4.1 Demographics of study participants 




N = 18 
Surgeon 2 
N = 18 
Surgeon 3 
N = 17 
Surgeon 4 
N = 17 
Total 
N = 70 
Female  
n, (%) 
11 (61.1%) 13 (72.2%) 9 (53%) 11 (64.7%) 
44 
(62.9%) 
Age (years),  
mean (SD) 














4.2 Recruitment and Attrition 
 
Sixty-four of the seventy participants enrolled in the study completed and returned 
the pain diary questionnaire pack following the seven days and were included in the 
final analysis. Failure to return the pain diary was considered failure of study 
completion. This was the sole reason behind participant attrition (Figure 4.1). 
 





4.3 Pre-operative assessment 
 
4.3.1 Hospital Anxiety and Depression Scale 
A single investigator (MC) was present to assist the study participants with 
completion of the HADS prior to surgery. Tables 4.2 and 4.3 show the distribution of 
study participants between the anxiety and depression subsets of the scale. The pre-
operative HADS data from one participant was absent. In our study population the 
vast majority, 75% in the anxiety subgroup and 89% in the depression subgroup were 
deemed not to be a case of psychological distress. Conversely, almost 15% in the 
anxiety scale and 3% in the depression scale were classified as probable cases. The 
cases are generally spread evenly throughout the surgeon groups, with no single 















































































































































































4.3.2 Pain Catastrophising Scale 
Each study participant completed a Pain Catastrophising Scale (PCS) as part of our 
baseline pre-assessment protocol (Appendix V). Table 4.4 demonstrates the 
number of study participants who reached a clinically relevant score on completion 
of the PCS. The number of ‘catastrophisers’ is very low overall, with 4 cases 
identified. One participant’s pre-operative questionnaire was incorrectly given to 
the patient at discharge, along with the seven-day pain diary, and unfortunately 
was not returned to us. 
 
Table 4.4 Patient characteristics for Pain Catastrophising Scale 
 Surgeon 1 Surgeon 2 Surgeon 3 Surgeon 4 Total 
Number of 
participants 
17 18 17 17 69 
Clinically relevant 
score >30 
1(5.9%) 0 1(5.9%) 2(11.8%) 4(5.8%) 
 
 
4.3.3 Effect of pre-operative assessment scores on pain 
Spearman’s correlation was used to measure the association between the pre-
operative questionnaire scores and the pain scores reported on the visual analogue 
scale. There was no significant correlation found between the pre-operative 
Hospital Anxiety or Depression scores and reported pain. There was a moderate 
positive association found between the pain catastrophising scale and the pain 
reported on the visual analogue scale (RS=0.369, P=0.017) 
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4.3.4 Oral Health Impact Profile 
Each patient completed a shortened version of the Oral Health Impact Profile (OHIP-
14) as a validated means of assessing the oral health-related quality of life 
experienced by our study population (Appendix VI). Table 4.5 shows the mean OHIP-
14 score of our study population as a whole and according to each surgeon group. 
There are high levels of consistency seen throughout the surgeon groups.  
 
Table 4.5 Patient characteristics OHIP-14 
 Surgeon 1 Surgeon 2 Surgeon 3 Surgeon 4 Total 
Number of participants 18 18 17 17 70 




4.4 Surgical Assessment 
 
4.4.1 State of Eruption 
Table 4.6 shows the frequency of distribution for the state of eruption of the 
mandibular third molar per treating surgeon group and total study population. Just 
two cases in total were assessed as not symmetrical in eruption, showing a high 
degree of agreement between the investigator and operating surgeons in their 
assessment of the teeth. One case of asymmetry was reported by Surgeon 1 and 
another single case by Surgeon 4. Almost half (45.7%) of the teeth removed during 
this clinical trial were found to be unerupted. 
 






























































































4.4.2 Classification of Impaction 
Table 4.7 shows the classification of impaction of the mandibular third molars as 
reported by the operating surgeon in that case. The type of impaction is reported as 
symmetrical in 97% of paired samples. This shows high levels of agreement between 
operating surgeon and the investigator (MC). Surgeon 3 and Surgeon 4 each reported 
a single case as being of involving teeth of differing impaction class. Overall, a 
majority of the teeth removed in this clinical trial (55%) were classified as a mesio-
angular impaction. Following from the mesio-angular cases, in decreasing order of 
frequency the cases involved in this trial included vertical impaction (21.4%), disto-
angular impaction (15%) and less frequently horizontally impacted (8.57) third 
molars. 
 
Table 4.7 Frequency Distribution for Winter Classification of Impaction 




































































































































































































4.4.3 Surgical technique 
Of the 140 mandibular third molars removed, 24 molars elevated out following the 
raising of a FMPF, releasing the soft tissue impaction. Seven paired samples (14 
teeth) were elevated out following the raising of a FMPF and subsequently sectioning 
the tooth using a hammer and osteotome. Thirteen of the 140 involved in the study 
required a FMPF, buccal bone removal with a rotary bur and irrigation coolant before 
the tooth was elevated out. Over 60% of cases (89 teeth) required the highest degree 
of surgical intervention to enable removal of the mandibular molar teeth, a FMPF, 
buccal bone removal with a rotary bur and irrigate combined with sectioning of the 
tooth itself before the elevation of the tooth in fragments from the socket. The 
surgical technique was identical in 95.7% of the cases involved in this clinical trial.  
Different surgical techniques were utilised for removal of third molars in three 
patients. Removal of these patients and reanalysis did not affect the direction of the 









Table 4.8 Frequency distribution of the Surgical removal technique employed 










(P = 100 × (F/N)) 
Extraction technique 
Surgeon 1 










































































































































4.4.4 Difficulty of Extraction 
We can see in Table 4.9 that no case was described by any surgeon as highly complex. 
Of the cases treated, 77.8% were deemed to be routine surgical extractions. 
 
























































































4.4.5 Duration of surgery  
Table 4.10 demonstrates the mean time in seconds for the surgical removal of the 
mandibular third molar. This was recorded separately for both the right and left side 
from incision to completion of final suture. There is some variability of surgery 
duration between surgeon groups. All surgeons had grossly similar caseloads of the 
various surgical techniques, raising the question does a decrease in surgery duration 
come with operator experience?   There is consistency seen for the duration of 
surgery within the surgeon groups for the intervention and control providing 
consistency within the paired samples and the pain scores reported by the 
participants. 
 
Table 4.10 Mean Surgery Duration for Intervention and Control Site 
Variable (n) Surgeon 1 Surgeon 2 Surgeon 3 Surgeon 4 Total 
Participants 
17 18 17 17 69 
Intervention side 












Control side  













4.4.6 Summary of Surgical Assessment 
Figure 4.2 represents the data collected from the surgical questionnaire graphically 
(Appendix VII). There is a high degree of consistency in the type of impaction (97%), 
state of eruption (97%) and surgical technique employed (95.7%) for removal 
between the intervention and control side.  
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Figure 4.2 Histogram depicting Surgical Variables 
 









4.5 Post-operative assessment 
 
4.5.1 Pain Diary 
Figure 4.3 graphically represents the findings from the structured pain diary. It can 
be seen in the graph that over 75% of participants reported experiencing some level 
of pain on post-operative day 2 – 5 inclusive. The diet of over 50% of the study 
population remained affected by surgery until day 7 following third molar removal.  
 
Figure 4.3 Bar Chart representing results from Pain Diary 
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4.5.2 Analgesic Consumption 
Each patient received a standard prescription and post-operative analgesic 
management advice. Figure 4.4 outlines the proportion of participants requiring 
analgesic medications each day and the number of each medication consumed. From 
post-operative day 0 to day 4 inclusive, 100% of study participants consumed some 
form of analgesic medication: 2% of participants did not consume any analgesics 
from post-operative day 5, with 14% of participants not using analgesics by post-
operative day 7. The proportion of participants requiring oxycodone as break through 
pain medication declined daily from post-operative day 3. The number of analgesics 


























4.5.3 Short Form McGill Pain Questionnaire 
Figure 4.5 outlines the eleven sensory terms and four affective terms used to 
describe pain in the Short Form McGill Pain Questionnaire (SF McGill). Tender, 
throbbing, and aching are consistently the most commonly-used characteristic terms 
to describe the sensory pain experienced. Exhausting is the most prevalent descriptor 
of the affective nature of the pain. 
 











The SF McGill also quantifies the overall present pain intensity experienced 
by the patient, using both a 100 mm visual analogue scale and a six-point Verbal 
Descriptor Scale (VDS), which has end points of ‘None’ to ‘Excruciating’. Figure 4.6 
represents the merged scores from the PPI and Visual analogue scale on each day 
post-op. The graph indicates the more severe descriptors on the VDS, ‘Horrible’ and 
‘Excruciating’ are most commonly used on post-operative day 2 and 3. 
 








4.5.4 Pain Assessment 
The VAS pain data was tested for normality using a Chi Squared Q-Q plot (Figure 4.7) 
and found not to be normally distributed. As a result, the data was analysed using 
non-parametric tests. 
 











4.5.6 Visual Analogue Scale 
Each study participant recorded the pain present on the right and left side 
independently using a 100mm visual analogue scale. This was completed daily from 
post-operative day 0 to day 7 inclusive, following surgery. As the data was not 
normally distributed, Wilcoxon Signed Rank test was used to analyse the paired data 
samples. Figure 4.8 illustrates each participant score reported for the intervention 
and control side. The mean pain score (full line) is marginally lower for the 
intervention (dexamethasone receiving) side. This was consistent across days 0 to 7 
post-operatively; however, this difference did not reach statistical significance. The 
daily p-value ranged from P=0.07 to P=0.73, never reaching statistical significance. 
 
Figure 4.8 Pain recorded on Visual Analogue Scale on Day 0 – Day 7 post-op. 
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Figure 4.9 illustrates the mean scores as reported on the visual analogue scale for the 
intervention and control site for seven days following treatment with the 95% 
confidence interval in shading. Although the graph demonstrates that pain scores in 
the dexamethasone-receiving sides were consistently lower than that in the control 
sides, the overlapping confidence intervals highlight that the difference in means 
between treatment and control is not significant. The whiskers represent the largest 






4.5.7 The effect of surgery duration on pain reported 
The data was analysed to see if there was an association between pain reported and 
the duration of the surgery for the intervention and control side. Figure 4.10 outlines 
the VAS score recorded for the intervention (dexamethasone receiving) and control 
site, alongside the duration of the surgical procedure. We can see there is a positive 
correlation between increasing surgical duration and pain reported on the VAS, 
however the overlapping confidence intervals indicate that it does not reach 
statistical significance. 
 
Figure 4.10 Effect of Surgical Duration on Pain Score 
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4.5.8 Linear mixed effects modelling 
The effect of the treatment (4mg submucosal injection of dexamethasone) was 
assessed with a mixed-effect linear regression model. The model used participants 
as the random effect, which was fit to the data following an iterative step-down 
procedure. The fixed effects included surgery time (seconds), tooth eruption state, 
and pain diary day. Tooth extraction technique, and impaction type were excluded 
from the model due to insignificant contributions to the fit (p > 0.05). Outliers in the 
data were treated by applying weights to the model according to pain diary day. The 
final model demonstrated that the reported pain scale (VAS 0-100mm) decreases 
moderately and significantly with the treatment (Estimate: -3.32, CI: -5.36 to -1.28, p 
< 0.01, Marginal R2 = 0.229, Conditional R2 = 0.526). It should be noted that although 
there is a consistent reduction in pain reported at the intervention site, this 
estimated reduction of pain is estimated to be -3.32 on the visual analogue scale 
which is a minimal change with doubtful clinical significance. 
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Table 4.11 Linear mixed-effects model 
  value 
Predictors Estimates CI p adjusted 
(Intercept) -21.32 -36.39 – -6.25 0.006 
Treatment [drug] -3.32 -5.36 – -1.28 0.002 
Surgery time 4.93 2.26 – 7.60 <0.001 
Eruption state 12.58 6.89 – 18.27 <0.001 
Pain diary day [1] 22.84 18.35 – 27.34 <0.001 
Pain diary day [2] 27.83 23.37 – 32.29 <0.001 
Pain diary day [3] 29.76 25.23 – 34.29 <0.001 
Pain diary day [4] 23.93 19.52 – 28.34 <0.001 
Pain diary day [5] 19.07 14.81 – 23.33 <0.001 
Pain diary day [6] 16.09 11.85 – 20.33 <0.001 
Pain diary day [7] 10.08 5.96 – 14.20 <0.001 
Random Effects 
σ2 384.63 
τ00 site.ID 240.89 
N site.ID 69 
Observations 1020 




4.5.9 Patient Satisfaction 
Figure 4.11 illustrates the findings reported in the Dental Visit Satisfaction Scale. 
78.12% of participants strongly agreed they were ‘satisfied with what the dentist did’. 
There was no unsatisfied patient following treatment and participation in the study. 
Over 75% of volunteers either strongly agreed or agreed they felt they knew what to 
expect in the weeks following surgery. The statement ‘The Dentist was too rough 
when he worked on me’ was not directly applicable to our study as the patient was 
under general anaesthetic while the procedure was being carried out and should 
have been excluded from the questionnaire. Nevertheless, regardless of the patient 
being under anaesthetic for the procedure 72% of volunteers strongly disagreed with 
the statement. 
 
A free comment was left by 51% of respondents on post-operative day 7. 
Positive comments included expressions of thanks for the theatre staff involved in 
the patient journey. For example, ‘All staff were very helpful and kind, provided 
excellent care’; ‘As very nervous patient I felt at ease’; ‘Very pleased with treatment: 
while I was in pain afterwards, this was expected and I felt the pain killers provided 
were very good’; ‘Staff fantastic, I was really pleased.’ 
 
Negative comments were related to the duration of pain and the duration of the 
recovery period. For example, ‘I wasn't aware there would be dead skin left, that was 
the worst part’; ‘Still slight pain, I did not expect it to take so long to recover’. Other 
study participants left comments which condensed their thoughts on the recovery 
period or their current status on the road to full recovery. For example; ‘No pain on 
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the left side of my mouth, right tender and slightly throbbing’; ‘Right side more 
swollen and took longer to return to normal’ and ‘Currently no discomfort on left 
side, small darting pain lower right’. 
 













4.5.10 Patient Preference 
On post-operative day 7 patients were asked to indicate their preference of treated 
side (right or left). The graph below, figure 4.12 shows the distribution of preference 
indicated for the intervention (dexamethasone receiving) and control side. 11% of 
participants did not indicate a preferred side. Of those who recorded a preference 
(59 volunteers), a slight majority (54%) indicated a preference for the 
dexamethasone receiving side. 
 











Surgeon 1 Surgeon 2 Surgeon 3 Surgeon 4 Total
Treatment preference 
Intervention Control No preference
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Chapter 5: Discussion and Conclusion 
5.1 Discussion 
 
5.1.1 Study design 
We conducted a randomised, controlled, split-mouth trial involving patients 
undergoing surgical removal of symmetrically impacted lower third molars. A split-
mouth trial is a study design in which each participant receives two or more 
treatment interventions in separate areas of the mouth (167). To be considered a 
‘split-mouth’ trial the treatment can be delivered to separate quadrants, such as in 
our study, or to separate surfaces of individual teeth or to different dental arches 
where suitable in other situations. This design concept was first introduced in 1968 
by Ramfjord et al. while investigating treatments of periodontal pockets (168). To 
suitably undertake this study design, a number of scientific assumptions need to be 
met. Specifically, the disease should be uniformly distributed and the effect of the 
intervention being evaluated should be localized and not ‘spill-over’ its effects to the 
comparison site (167). To address these scientific assumptions, our inclusion criteria 
restricted participants to those with symmetrically impacted mandibular third 
molars. Furthermore, our intervention under investigation, 4mg of dexamethasone 
was to be administered as a submucosal injection local to the surgical site. The 
submucosal nature of the injection retains the medication, localized in the soft 
tissues surrounding the surgical site, as opposed to a topical or systemic 
administration of the drug which could disperse around the oral cavity, affecting the 
control side. For split-mouth trials, randomisation is within the study site as opposed 
to within the study population. Each volunteer is to receive all intervention 
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modalities. In order to ensure equal number of participants received our intervention 
or control on the right or left side of the mouth respectively, we used blocked 
randomisation in combination with a random number generator to provide our 
sequence. 
 
Each patient acts as their own control, providing paired samples, thereby 
greatly controlling background variation and limiting inter-individual variability, such 
as gender, age, race, smoking status, bone density, personality, dental anxiety, 
relationship with pain and analgesia. In the literature there is some criticism of split 
mouth trials surrounding a possible cross-over effect. The concern is that the 
participant would bring their experience of one procedure to the second procedure, 
creating an observer bias. This observer bias can be defined as an unconscious 
distortion of observations as a result of preconceived notions (169). Our study design 
addressed this potential limitation by having each participant undergo both the 
control and intervention during one single procedural appointment. In addition to 
this, all treatment is carried out while the patient is under general anaesthetic 
thereby ensuring participant blinding of the assigned intervention site.  
 
The investigator, surgeons and participants were blinded to the 
randomisation sequence by having an independent statistician carrying out this task. 
The investigator (MC) was blinded to the assigned intervention site by not being 
present in theatre for the procedure. The randomisation site for each case was 
contained in an opaque envelope until directly given to the operating surgeon 
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immediately prior to the procedure, in order to further ensure concealment. These 
details were discarded following the procedure and the randomisation sequence was 
held confidentially with the statistician until all the data had been collected and 
input.  
 
A strength of the split-mouth study design is that it can enhance the statistical 
power of a study. Due to the paired data samples, a split-mouth study can obtain a 
more powerful estimate of treatment effect with a smaller sample size. In today’s 
society, where time and financial constraints are substantial, a well-designed split-
mouth trial can allow the maximum amount of information be obtained from a trial 
and from each participant. A further advantage of this study design is that it allows 
determination of patient preference as each study participant has undergone both 
modalities.   
 
Limitations of the study-design were minimised. A known limitation of split-
mouth trials includes the restrictions on recruitment of participants due to the 
requirement of symmetrical disease patent. It could be challenged that due to the 
restriction of recruitment to those with symmetrically impacted mandibular third 
molars our team could have an effect on the external validity of the trial. As third 
molar impaction is almost commonplace across many different groups in society we 
do not see this as a disadvantage in our study (50, 51). In clinical trials where a 
pathologic process exists, for example caries rate or periodontitis is being 
investigated, a split-mouth design where participants are limited to those with caries 
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or severe periodontal disease in two or more quadrants may not have external 
validity as recruitment criteria is limited to those with high disease prevalence (170, 
171).   
 
Our clinical trial engaged four operating surgeons of varying degrees’ 
experience to carry out the surgery. Each surgeon was experienced and registered 
on the Specialist Register of Oral Surgeons held by the Irish Dental Council for the 
duration of the trial. Having four surgeons of differing experience represents a 
strength of the study.  A relatively large and varying pool of operators makes the trial 
outcomes valid and applicable to Specialist Oral Surgeons as a whole community. This 
is in contrast to a trial which involves one highly experienced or skilled surgeon, in 
which the findings may lack external validity. The fact that study participants were 
recruited from the Cork University Dental School, and represent a cohort who had 
been referred by another dental professional, either their general dentist or 
orthodontist, somewhat limits the applicability of the results to oral surgeons as 
opposed to general dentists undertaking third molar removal in community practice. 
 
We based our sample size and power calculation on a study of similar design 
with the same primary outcome measure (20). Allowing for a potential non-
completion rate of 25% a study population of 70 was recruited. Due to the paired 
samples and reduced variability a sample population of this relatively low size was 
suitable. An alternative approach to estimating the standard deviation is that was 
could have run an internal pilot study to calculate a more accurate standard deviation 
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and required sample size, however due to time and financial constraints along with 
lack of direct access to an independent statistician this option was not feasible.   
 
Our study was designed to detect a difference in mean VAS score between 
treatment groups of 10 mm. There is no consensus available as to what mean change 
in VAS constitutes a clinically meaningful difference for patients undergoing third 
molar removal (172). One Dutch study investigated what would be a clinically 
relevant change in VAS following third molar removal; however the study is of low-
quality (172). The volunteers were recruited from a population who were already 
participating in one of three different third molar removal studies. Each participant 
was undergoing removal of one third molar, however the three trials were 
incorporating different removal techniques. Furthermore, the state of eruption, 
classification of impaction or the presence of pathology was not disclosed in this trial, 
all surgical factors which could have a direct impact on the post-operative pain score 
reported by the patient. In this Dutch study data was collected with respect to a 
100mm VAS three times daily on days 1 -7 inclusive following removal. A Global 
Perceived Effect scale was completed on day 2 and day 7 following surgery asking 
participants to provide evaluation of their recovery on a seven-point scale. This trial 
reported a relative pain reduction of 50% on the VAS or an actual pain reduction of 
25mm on the VAS as a meaningful reduction. The GPE scale asks patients to rate on 
a numerical scale how much their pain has improved or deteriorated over a period 
of time (173). It is questionable whether this is an appropriate tool for comparing 
pain following third molar removal. This tool is designed to compare a base-line pain 
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and comparison with pain scores reported following an intervention. Often those 
having their third molars removed have no pain immediately pre-operatively and 
there is significant pain which gradually decreases following surgery. Other tools such 
as the Minimal Importance Difference (MID) are used in conjunction with the VAS, 
but again these tools are designed to investigate the change in chronic pain rather 
than acute surgical pain (174). Prior to commencing further clinical trials investigating 
pain as a primary outcome measure it would be worth calculating what is a clinically 
significant reduction in pain for this cohort. We estimated a reduction of 10mm on 
the visual analogue scale as clinically meaningful. However, a difference of 20mm or 
greater may provide more impactful findings. It is our opinion that a difference of 
less than 10mm on the VAS or a change of less than ten percent on any pain reporting 
tool is unlikely to have a clinically meaningful difference for the patient population.  
 
Our primary method of data collection was via questionnaires. We created a 
booklet format, incorporating the Pain Diary, Short Form McGill Pain Questionnaire 
and Dental Visit Satisfaction Scale to ensure ease of completion for the participants 
in the week following surgery. A booklet format also gives a professional appearance 
to the questionnaires (175). All questionnaires used simple language, free from 
medical jargon to allow for varying cognitive ability amongst the participant 
population. We aimed to keep the number of questionnaires used throughout the 
study to a minimum to increase responder compliance. Each study participant was 
given a stamped addressed envelope to encourage return of the questionnaire 
booklet on completion of the data collection period. Previous studies have found this 
can increase response rate (176). 
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Structured pain diaries are commonly used as a tool in clinical practice across 
a range of specialities to track a patient’s symptoms. Human recall of past events has 
its limitations, even more so when trying to recall previous symptoms while sitting in 
a clinician’s surgery. Pain diaries are a clinician’s solution toward capturing accurate 
data from patients reporting in real-time rather than relying on recall at a review or 
follow-up appointment (177, 178). However, it has been shown that pain dairies 
actually increase patient perception of symptom severity (179). In a study 
investigating patients’ recovery following acute lumbar back pain in which two 
groups of patients were followed, one group were required to complete a pain diary, 
the other were not. Commencing the study both groups had similar recall of 
symptoms, however following completion of a pain diary that group had symptom 
amplification at subsequent follow-up (179). Another study by the same group found 
that the use of a pain diary actually slowed the recovery in patients’ suffering from 
whiplash injury (180). Pain diaries can act as an aid to facilitate communication 
between the patient and clinician. In this clinical trial, a pain diary was used to 
capture the pain intensity at two different sites in the same patient. Any amplification 
of symptoms, for example due to pre-existing pain catastrophising tendencies, would 
be mirrored for both the right and left surgical sites. As our outcome measurement 
was a difference between two sites in a paired sample, rather than an overall pain 
score, any symptom amplification should be reflected in pain scores at both surgical 
sites. For this purpose of recording a difference in pain over two sites within on 
patient, the pain diary is a suitable and appropriate tool to allow real-time reporting 
of experience by the patient. 
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5.1.2 Study Population Characteristics 
Seventy patients were enrolled in the study. The age range of the participants was 
16 to 54 years of age, with the mean age being 22 years. This is in keeping with other 
studies involving third molar removal (16, 181). The age range in our study and others 
reflect the age when mandibular third molars erupt and have the potential to cause 
problems for the patient. Thirty-three of the seventy cases included in our study 
involved third molars that were classified by the surgeon as unerupted. In our 
department, patients listed to undergo orthognathic surgery routinely have 
unerupted mandibular third molars removed, if present, 6-12 months prior to the 
bilateral sagittal split osteotomy. This would account for the large proportion of study 
participants having unerupted, asymptomatic third molars removed.  
 
Our inclusion criteria limited study participants to those that were fit and 
healthy, with only those classified as ASA1 or ASA2 included. Non-smokers accounted 
for 83% of participants. These restrictions on study subjects may make the findings 
less applicable to the general population. However, examining the data reported by 
the Central Statistics Office we see a prevalence of 17% of the population over 15 
years of age are smokers. This data corresponds well with our study population (182). 
Forty-four of the 70 participants were female. Males and females have been shown 
to have differing pain thresholds and levels of pain tolerance (183). Females are 
known to be more likely to seek treatment for medical issues than their male 
counterparts and our study population is reflective of this (183). As we undertook a 
split-mouth study design, each patient reported on both the intervention and control 
site providing matched pairs of data. As we were looking for a difference in pain 
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reported within each individual participant, the confounding factors that may have 
been present if we were comparing VAS scores between participants is removed. 
With this study design we did not require equal number of male and female 
participants. 
 
Our study used validated tools in the form of the Hospital Anxiety and 
Depression Scale and the Pain Catastrophising Scale in order to gather a baseline 
overview of the psychological variables of participants included in our study 
population (138, 184). Non-surgical factors have been shown to impact on the pain 
reportedly experienced by the patient (185). The paired samples investigated in a 
split-mouth study such as ours negates many of these non-surgical factors by design. 
With each participant reporting on both the intervention and control, combined with 
the analysis focusing on the difference between these paired samples the inter-
participant variability has less impact on the final study outcomes.  Nonetheless, 
these questionnaires may provide useful data beyond patient demographic details. 
Our volunteer cohort was found largely to be a non-anxious, non-distressed 
population. These questionnaire scores are helpful to have to investigate if they have 
impact on the pain reported on the visual analogue scale. Our post-hoc linear effects 
model found the results from the Pain Catastrophising Scale and the Hospital Anxiety 
and Depression Scale did not have an impact on pain reported by the individuals in 
our study population. The level of potential anxiety, depression and catastrophising 
amongst our volunteers was relatively evenly distributed between the four operating 
surgeon groups. Treatment may be carried out under general anaesthetic for a 
number of reasons including some clinician-orientated factors such as the difficulty 
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of the procedure and some patient-orientated factors such as anxiety. Fear of the 
dentist is one of the most commonly reported fears (186). The reason for this anxiety 
is usually multi-factorial but can be contributed to by previous personal experience, 
experiences of family and friends or a more general anxiety trait of an individual 
(187). Within our study population we identified 25% of participants of being either 
a borderline or probable case of anxiety. This is not unexpected when dental fear is 
so common, estimated at 36% of the general population in the United Kingdom, 
combined with the surgical nature of third molar removal giving rise to greater 
anxiety or fear than something less daunting such as a dental check-up (188). 
Through the use of pre-operative questionnaires in our study population we 
identified a moderate positive association found between the scores reported in the 
Pain Catastrophising Scale and the pain reported on the Visual Analogue Scale. In the 
post-hoc linear effect model, the score derived from the Pain Catastrophising Scale 
did not affect the outcome in the step-down process so it was not included in the 
final model. We identified no significant correlation between the pre-operative 
Hospital Anxiety or Depression Scores and reported pain in our study population.  
 
5.1.3 Surgical Assessment 
There were almost equal numbers of patients requiring the removal of unerupted 
(46%) and partially erupted (54%) lower third molars within our study population. 
These cases were listed for the surgeons in order of placement on the general 
anaesthetic waiting list at Cork University Dental School. Surgeon 3 and Surgeon 4 
had a greater proportion of unerupted third molar cases, with Surgeons 1 and 2 
having a greater proportion of partially-erupted cases. As the speed of surgery, or 
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patient outcomes of the surgeon as individuals, were not being investigated this is 
not seen as having an impact on our primary outcome measurement of pain. 
However, we did note a moderate association between the state of eruption of the 
impacted third molar and pain scores reported in each case. This association was 
supported by its influence on the post-hoc linear effects model (estimates 12.58, CI 
6.89 – 18.27, P <0.001). 
 
 All cases invited to participate and subsequently enrolled in the study were 
assessed radiographically by a single investigator (MC) and deemed to have 
symmetrically erupted and impacted mandibular third molars. Symmetry is a crucial 
aspect in our study-design in order to minimise any anatomical reason for different 
levels of pain to be experienced at either surgical site except for the intervention. 
Due to waiting times, there can sometimes be months between placement on a 
treatment waiting list and the treatment being undertaken. In some cases, the state 
of eruption at one site may have changed from what is observed on the radiograph. 
Pre-operatively a single investigator (MC) was able to assess easily if there was a 
difference in state of eruption intra-orally by simply looking in the patient’s mouth. 
If one tooth was visible and the other not, the subject was no longer eligible for 
inclusion in the trial. The type of impaction is not as easily assessed in this way by the 
investigator prior to surgery, so there is greater reliance on the relevant radiograph. 
For example, in some cases radiographic assessment has identified symmetrical 
impaction and due to factors such as time, pathology, loss of adjacent teeth the 
classification may have progress and changed. Alternatively, when assessed from a 
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different perspective, such as intra-orally during removal, a tooth radiographically 
assessed as vertically impacted could now be classified as distoangular. This could be 
due to the positioning of the patient for the radiograph, the angulation of the x-ray 
beam or further growth of the patient or through assessor variability. There was 
excellent agreement observed between Surgeon 1, Surgeon 2 and the investigator 
with 100% of cases classified as symmetrically impacted. Surgeon 3 and Surgeon 4 
each reported a single case involving asymmetrically impacted third molars for 
removal. These high levels of agreement between the operating surgeons and the 
investigator support the internal validity of the study with respect to the inclusion 
criterion. 
 
 A variety of surgical techniques was employed by each surgeon in the course 
of the trial. Technique used is determined by the type of impaction of the tooth in 
combination with operator preference. Surgeon 1 was the only operator to utilize 
the ‘Hammer and Osteotome’ as a technique. When previously compared to other 
techniques the hammer and osteotome was found to have a shorter healing period 
(78). Regardless of the technique employed it is operator experience that has been 
demonstrated to impact on patient-reported pain experienced in the recovery period 
(79, 80). 
 
 There have been many attempts at creating a valid tool for predicting the 
difficulty of the extraction such as Macgregor’s ‘WHARFE’ assessment tool, Winter’s 
lines, and the Pell and Gregory classification (53, 54, 189). These tools base their 
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estimate exclusively on radiographic variables. None have been found to be widely 
validated or accepted as an accurate predictor. Tools that rely completely on 
radiographic assessment do not take into consideration factors that may not be 
visible on the radiograph. Research published more recently suggests that difficulty 
cannot be predicted pre-operatively but only intra-operatively (190). Immediately 
following the procedure, the surgeon recorded if the removal was ‘Routine’, 
‘Complex’ or ‘Highly complex’. The choice of classification of difficulty was entirely at 
the discretion of the treating surgeon. The aim of recording this surgeon-reported 
outcome was to provide a possible explanation to any outliers in the pain score data; 
however, none of the four surgeons reported any of the 140 individual cases of third 
molar removal as ‘Highly Complex’.  
 
 The use of patient-centred outcome measures in medicine and surgery has 
been substantially increasing over the past number of decades (191-193). Patient-
reported outcomes offer valuable information on the effects of an illness or 
intervention as perceived by the patient. There is a growing body of evidence 
reporting that oral disorders or conditions can have a significant impact on an 
individual’s physical, mental and social well-being (194). The short version Oral 
Health Impact Profile has been shown to be a practical and valid tool in an oral 
surgery setting (195). In this trial, volunteers were asked to complete the OHIP-14 
questionnaire pre-operatively in order to measure the impact the presence of third 
molars had on the patients’ quality of life. The fourteen questions can be divided into 
seven subscales; including functional limitation, physical pain, physical disability and 
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social disability. Patients are required rate each statement on a Likert-type scale and 
a summary or weighted score can be calculated. In our study many of the participants 
had never experienced pain with respect to their third molars, which is not typical of 
a cohort imminently undergoing removal.  Almost half of participants (47%), were 
having the teeth removed in advance of orthognathic surgery. With this knowledge 
one might speculate that the OHIP scores from these participants would be 
significantly lower than those who were having their teeth removed due to 
pathology, however this was not found to be the case in our cohort. All study 
participants scored virtually the same summary score on the OHIP-14 questionnaire. 
Those individuals with unerupted, pathology and problem-free third molars, may 
have been undergoing extensive orthodontic intervention resulting in them scoring 
highly in the psychological and physical disability domains: ‘Have you ever felt self-
conscious about your teeth?’; ‘Have you ever had to interrupt meals because of your 
teeth?’ or ‘Have you found it uncomfortable to eat any food because of problems 
with your teeth?’ The instructions given to the study participants should have been 
more explicit regarding focusing on the impact of the third molars alone on oral 
health alone.  A further limitation of the study is that the OHIP-14 questionnaire was 
only completed by participants on one occasion, pre-operatively. It may have added 
significant value if it had been repeated at a date post–operatively to establish if 
there had been an improvement in perceived oral health. It must be acknowledged 
that this questionnaire was originally intended to assess the long-term effects on oral 
health related quality of life and may not be the ideal tool for assessing the effects of 




Due to its safety-profile, low-cost, half-life and potency, dexamethasone has been 
described as an ideal corticosteroid (196). In our study we investigated an 
intervention of 4mg dexamethasone delivered as a 1ml submucosal injection buccal 
to the surgical site. Other potential routes of administration include oral, 
intravenous, intramuscular and oral. We focused our trial on the submucosal route 
as we wanted to avoid any potential systemic side-effects associated with oral or 
intravenous corticosteroids. Furthermore, for oral surgeons or dental practitioners, 
administration as a submucosal injection would be considered a safe and easy route 
as they are comfortable with intra-oral injections. With a submucosal injection 
administered buccal to the surgical site, the surgeon can target the delivery of the 
corticosteroid to a specified location.  
 
 Our study is consistent with others that report there is a direct association 
between duration of surgery and post-operative pain reported (197). Our post-hoc 
analysis comparing the dexamethasone receiving intervention site versus the control 
found some evidence that submucosal dexamethasone had a greater beneficial 
effect on the surgeries of longer duration although this did not reach statistical 
significance (Figure 4.10). Furthermore, the reduction in pain reported is estimated 
at 4.93mm on the visual analogue scale with a 95% confidence interval range of 2.26–
7.60, which does not represent a clinically meaningful difference. 
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5.1.5 Post-operative complications  
With respect to post-operative complications, a potential limitation of the study 
design is that the investigator did not review the patient and the surgical site in 
person following treatment. As such, we do not have an accurate or reliable 
measurement of the rate of post-operative complication such as dry socket or 
infection. Following the removal of third molars there is a wide ranging reported 
incidence dry-socket following treatment (198). Other more serious post-operative 
complications include temporary or permanent paraesthesia in the distribution of 
the inferior dental or lingual nerve (199). Indirectly, through our structured pain 
diary, we can estimate the incidence of complication using the question ‘did you see 
a dentist for complications associated with your surgery today?’. Our pain diary 
records that a dentist was contacted on 13 occasions by our study population in the 
week following surgery. We are using this figure as a proxy to estimate a complication 
rate amongst our volunteers, however this is a flawed method of assessing 
complications. This figure presumes the assessing dentist confirmed a complication 
for each attending patient. Furthermore, the number calculated could account for 
the same patient returning to the dentist on multiple occasions. Ideally, each patient 
would have returned to the single investigator (MC) or a dedicated, suitably-qualified 
research assistant for review of any potential complications or post-operative 
concerns. Due to patient factors such as the distance required to travel and lack of 
funding for a research assistant this was not possible. 
 
 Through our Dental Visit Satisfaction Scale, we established that patients 
reported high levels of satisfaction following treatment. However, it must be noted 
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that we may have been able to improve on the psychological preparation of the 
patients. Approximately 20% of patients disagreed with the statement ‘I have a good 
idea what to expect in the next few weeks’. Studies have demonstrated the 
importance of communication and explanation of the post-operative recovery period 
is associated with greater levels of patient satisfaction (200). 
 
5.1.6 Patient Preference 
On day 7 following surgery we asked the patients which treatment site they 
preferred. A very slight majority of respondents (33 patients) indicated preference 
towards the intervention side. The control side was preferred by 29 patients. Any 
intervention should have a benefit to the patient. The reasoning behind our study 
and the addition of a submucosal injection of dexamethasone to the protocol of 
surgical removal of impacted third molars is to reduce the pain experienced by the 
patient. This narrow margin of preference between the intervention and control sites 
indicates that the marginal difference in pain outcome was not clinically meaningful 
to the patient, further supporting the statistical comparisons of the VAS pain scores 
between intervention and control, where no sizeable difference in pain score was 
apparent. 
 
5.1.7 Implications for practice 
This study has shown a consistent, but very marginal reduction in pain reported at 
the dexamethasone-receiving site compared to the control site. Following regression 
analysis, the estimated mean reduction seen was -3.34mm on the 100mm visual 
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analogue scale. A reduction of this size does not indicate any meaningful clinical 
value. As a result, I would not change my current surgical protocol based on these 
results alone and would not advocate for the routine use of submucosal 
dexamethasone injections in the extraction of impacted third molars. In certain 
clinical scenarios, such as third molar surgery of long duration (15 minutes or 
greater), there is a greater reduction in pain reported at the intervention site by the 
patient and this may justify the intervention. We propose that each surgical site 
would be assessed independently by the treating clinician. Due to the drug 
administration close to the surgical site, low dosage of drug required for effect and 
low systemic absorption of the drug it is reasonable to recommend bilateral 
administration of submucosal dexamethasone if the clinical scenario required it. 
However, further research tasked specifically at answering this question is required 





Currently, due to the low quality research available, the medical literature reports 
mixed outcomes in the administration of submucosal dexamethasone for analgesic 
improvement in the extraction of impacted, third molar teeth. Our goal, through 
conduction of a randomised, double-blind, controlled trial using a split-mouth study 
design, was to determine whether there is patient benefit and greater analgesic 
effect when submucosal dexamethasone is administered prior to the extraction of 
impacted third molars. The null hypothesis states there is no difference in post-
operative pain following surgical removal of lower third molars when a submucosal 
injection of 4mg dexamethasone is administered in the buccal vestibule pre-
operatively. Consistently across days 1 to 7 post-operatively, this trial demonstrated 
a minor improvement in analgesic effect when submucosal dexamethasone was 
administered in comparison to control, supporting the alternative hypothesis. 
However, it must be considered the effect size detected was minimal (estimated 3% 
improvement) and not clinically meaningful for patients. Therefore, the routine use 
of submucosal dexamethasone injection in the extraction of impacted third molars 
should not be recommended. Post-hoc analysis suggested that for prolonged 
duration of extraction (>15 minutes), a greater analgesic effect may be seen with 
submucosal dexamethasone treatment. However, further, targeted studies are 
required to investigate this. 
 
The secondary aim of the trial was to determine patients’ post-operative 
preference and satisfaction with regard to a submucosal injection of dexamethasone 
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versus local anaesthetic alone during lower third molar extraction. Each patient was 
asked to indicate their preferred side of treatment on day 7 post-op. Of those who 
responded only a narrow majority of 54% indicated preference for the intervention 
receiving side. The lack of concordance between the patients preferred side of 
treatment and the side receiving dexamethasone casts further doubt on the utility 
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Consent for participation in research study 
  
AGREEMENT 
The research project and the procedures associated with it have been fully explained to 
me.  I have had the opportunity to ask questions concerning all aspects of the project 
and any procedures involved.  I am aware that participation is voluntary and that I may 
withdraw my consent at any time.  I am aware that my decision not to participate or to 
withdraw will not restrict my access to health care services normally available to me.  
Confidentiality of records concerning my involvement in this project will be maintained in 
an appropriate manner.  When required by law, the records of this research may be 
reviewed by government agencies and sponsors of the research.  
I understand that the sponsors and investigators have such insurance as is required by 
law in the event of injury resulting from this research.  
I, the undersigned, hereby consent to participate as a subject in the above described 
project conducted at University Dental School and Hospital, Cork.  I have received a 
copy of this consent form for my records.  I understand that if I have any questions 
concerning this research, I can contact the Chief Investigator listed above.  I understand 
that the study has been approved by the Cork Research Ethics Committee of the Cork 
Teaching Hospitals (CREC) and if I have further queries concerning my rights in 
connection with the research, I can contact CREC at Lancaster Hall, 6 Little Hanover 
Street, Cork, 021 4901901. 
  
Please circle yes or no for the questions that follow: 
I have read and understand the study:   Yes  /  No 
I agree to participate in this research:   Yes  /  No 
I grant permission for the data collected to be used in this research only:   Yes  /  No 
I understand that my anonymised data will be stored at University Dental School and 
Hospital, Cork for seven years:              Yes  /  No 
 
Chief Investigator Signature: ___________________________ 
 
Signature of Study Participant: ______________________________ 
 
Witness Signature (if applicable): ___________________________ 
 





PATIENT INFORMATION SHEET FOR RESEARCH STUDY 
Patient Name: ____________________________  
Study Title:  
Evaluation of the effect of submucosal dexamethasone injection in patients undergoing third 
molar removal in terms of pain experienced and impact on quality of life, a randomised 
control trial. 
Name of Chief Investigator:  Dr Catherine Gallagher 
Contact Number for Chief Investigator: 021 4901170 
You are being asked to participate in a research study. In order to decide whether or not you 
want to be a part of this research study, you should understand enough about its risks and 
benefits to make an informed judgment.  This process is known as informed consent.  This 
consent form gives detailed information about the research study.  The Chief Investigator will 
also discuss the study with you in detail. When you are sure you understand the study and 
what will be expected of you, you will be asked to sign this form if you wish to participate. 
 
Nature and Duration of the procedure: The aim of this research is to look at the effect of a 
localized steroid injection around the area the tooth had been removed. Specifically, does 
this improve quality of life in the recovery period for you as the patient. All other aspects of 
your treatment will be standard procedure. You will receive local anaesthetic on both sides 
of your mouth that lasts on average 2-3 hours. One side will receive an additional injection of 
a steroid, dexamethasone. Some pain is expected after wisdom tooth extraction despite 
being numb. We want to look at how satisfied you are following your extraction and if there is 
a difference in pain at either extraction site. You will be required to fill out a pain diary and 
questionnaire once daily for 1 week following surgery. A stamped addressed envelope will 
be provided for ease of returning the questionnaires to us. There will be no additional 
appointments required. 
The surgery will be carried out by an experienced Oral surgeon. A single experienced oral 
surgeon will carry out both the right and left extraction. 
 
Potential Risks and Benefits: There are no additional risks associated with taking part in 
this study, other than those already associated with wisdom tooth removal. 
 
Possible alternatives: Your participation is entirely. Whether you agree to take part or not 













PAIN CATASTROPHISING SCALE 
 
Name:      Patient CDS: 
Date:      Patient Ref: 
 
Everyone experiences painful situations at some point in their lives. We are 
interested in the types of thoughts and feelings that you have when you are in pain. 
Listed below are thirteen statements describing different thoughts and feelings that 
may be associated with pain.  
 
Using the following scale, please indicate the degree to which you have these 
thoughts and feelings when you are experiencing pain. 
 
0= not at all 1=to a slight degree 2=to a moderate degree 3=to a great degree 4=all 
the time  
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